|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Palma M and Lewis CE: Cancer:
Macrophages limit chemotherapy. Nature. 472:303–304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nielsen SR and Schmid MC: Macrophages as
key drivers of cancer progression and metastasis. Mediators
Inflamm. 2017:96247602017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ruffell B and Coussens LM: Macrophages and
therapeutic resistance in cancer. Cancer Cell. 27:462–472. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH,
Wang XZ, Zhao YW and Wei YQ: Prognostic significance of
tumor-associated macrophages in solid tumor: A meta-analysis of the
literature. PloS One. 7:e509462012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Birbrair A, Zhang T, Wang ZM, Messi ML,
Olson JD, Mintz A and Delbono O: Type-2 pericytes participate in
normal and tumoral angiogenesis. Am J Physiol Cell Physiol.
307:C25–C38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shih JY, Yuan A, Jeremy JW and Yang PC:
Tumor-associated macrophage: Its role in cancer invasion and
metastasis. J Cancer Mol. 101–106. 2006.
|
|
9
|
Frankenberger C, Rabe D, Bainer R,
Sankarasharma D, Chada K, Krausz T, Gilad Y, Becker L and Rosner
MR: Metastasis suppressors regulate the tumor microenvironment by
blocking recruitment of prometastatic tumor-associated macrophages.
Cancer Res. 75:4063–4073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Green CE, Liu T, Montel V, Hsiao G, Lester
RD, Subramaniam S, Gonias SL and Klemke RL: Chemoattractant
signaling between tumor cells and macrophages regulates cancer cell
migration, metastasis and neovascularization. PloS One.
4:e67132009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wyckoff J, Wang W, Lin EY, Wang Y, Pixley
F, Stanley ER, Graf T, Pollard JW, Segall J and Condeelis J: A
paracrine loop between tumor cells and macrophages is required for
tumor cell migration in mammary tumors. Cancer Res. 64:7022–7029.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhattacharya S, Michels CL, Leung MK,
Arany ZP, Kung AL and Livingston DM: Functional role of p35srj, a
novel p300/CBP binding protein, during transactivation by HIF-1.
Genes Dev. 13:64–75. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braganca J, Eloranta JJ, Bamforth SD,
Ibbitt JC, Hurst HC and Bhattacharya S: Physical and functional
interactions among AP-2 transcription factors, p300/CREB-binding
protein, and CITED2. J Biol Chem. 278:16021–16029. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chou YT, Wang H, Chen Y, Danielpour D and
Yang YC: Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Oncogene. 25:5547–5560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Glenn DJ and Maurer RA: MRG1 binds to the
LIM domain of Lhx2 and may function as a coactivator to stimulate
glycoprotein hormone alpha-subunit gene expression. J Biol Chem.
274:36159–36167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lau WM, Doucet M, Huang D, Weber KL and
Kominsky SL: CITED2 modulates estrogen receptor transcriptional
activity in breast cancer cells. Biochem Biophys Res Commun.
437:261–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tien ES, Davis JW and Vanden Heuvel JP:
Identification of the CREB-binding protein/p300-interacting protein
CITED2 as a peroxisome proliferator-activated receptor alpha
coregulator. J Biol Chem. 279:24053–24063. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qu X, Lam E, Doughman YQ, Chen Y, Chou YT,
Lam M, Turakhia M, Dunwoodie SL, Watanabe M, Xu B, et al: Cited2, a
coactivator of HNF4alpha, is essential for liver development. EMBO
J. 26:4445–4456. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu B, Qu X, Gu S, Doughman YQ, Watanabe M,
Dunwoodie SL and Yang YC: Cited2 is required for fetal lung
maturation. Dev Biol. 317:95–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin Z, Haynie J, Yang X, Han B,
Kiatchoosakun S, Restivo J, Yuan S, Prabhakar NR, Herrup K, Conlon
RA, et al: The essential role of Cited2, a negative regulator for
HIF-1alpha, in heart development and neurulation. Proc Natl Acad
Sci USA. 99:pp. 10488–10493. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bai L and Merchant JL: A role for CITED2,
a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS
Lett. 581:5904–5910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou YT, Hsieh CH, Chiou SH, et al: CITED2
functions as a molecular switch of cytokine-induced proliferation
and quiescence. Cell Death Differ. 19:2015–2028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jayaraman S, Doucet M and Kominsky SL:
Down-regulation of CITED2 attenuates breast tumor growth, vessel
formation and TGF-β-induced expression of VEGFA. Oncotarget.
8:6169–6178. 2017.PubMed/NCBI
|
|
25
|
Jayaraman S, Doucet M, Lau WM and Kominsky
SL: CITED2 modulates breast cancer metastatic ability through
effects on IKKα. Mol Cancer Res. 14:730–739. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lau WM, Weber KL, Doucet M, Chou YT, Brady
K, Kowalski J, Tsai HL, Yang J and Kominsky SL: Identification of
prospective factors promoting osteotropism in breast cancer: A
potential role for CITED2. Int J Cancer. 126:876–884.
2010.PubMed/NCBI
|
|
27
|
Sun HB, Zhu YX, Yin T, Sledge G and Yang
YC: MRG1, the product of a melanocyte-specific gene related gene,
is a cytokine-inducible transcription factor with transformation
activity. Proc Natl Acad Sci USA. 95:pp. 13555–13560. 1998;
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chou YT and Yang YC: Post-transcriptional
control of Cited2 by transforming growth factor beta. Regulation
via Smads and Cited2 coding region. J Biol Chem. 281:18451–18462.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. 8th.
Washington (DC): National Academies Press (US); 2011, ISBN-13.
ISBN: 978-0-309-15400-0ISBN-10. ISBN: 0-309-15400-6PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantiative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baay M, Brouwer A, Pauwels P, Peeters M
and Lardon F: Tumor cells and tumor-associated macrophages:
Secreted proteins as potential targets for therapy. Clin Dev
Immunol. 2011:5651872011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bingle L, Lewis CE, Corke KP, Reed MW and
Brown NJ: Macrophages promote angiogenesis in human breast tumour
spheroids in vivo. Br J Cancer. 94:101–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aharinejad S, Paulus P, Sioud M, Hofmann
M, Zins K, Schäfer R, Stanley ER and Abraham D: Colony-stimulating
factor-1 blockade by antisense oligonucleotides and small
interfering RNAs suppresses growth of human mammary tumor
xenografts in mice. Cancer Res. 64:5378–5384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beider K, Abraham M, Begin M, Wald H,
Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E, et
al: Interaction between CXCR4 and CCL20 pathways regulates tumor
growth. PloS One. 4:e51252009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goswami S, Sahai E, Wyckoff JB, Cammer M,
Cox D, Pixley FJ, Stanley ER, Segall JE and Condeelis JS:
Macrophages promote the invasion of breast carcinoma cells via a
colony-stimulating factor-1/epidermal growth factor paracrine loop.
Cancer Res. 65:5278–5283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schutte M, Hruban RH, Hedrick L, Cho KR,
Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H,
et al: DPC4 gene in various tumor types. Cancer Res. 56:2527–2530.
1996.PubMed/NCBI
|
